Skip to main content
HLB SCIENCE Inc. logo

HLB SCIENCE Inc. — Investor Relations & Filings

Ticker · 343090 ISIN · KR7343090007 KO Professional, scientific and technical activities
Open in API
Filings indexed 187 across all filing types
Latest filing 2021-03-11 Proxy Solicitation & In…
Country KR South Korea
Listing KO 343090

About HLB SCIENCE Inc.

https://hlbscience.com/eng/index.php

HLB SCIENCE Inc. is a biopharmaceutical company specializing in the development of innovative drugs and diagnostics for infectious and immune-related diseases. The company's primary research focuses on creating therapeutics for sepsis, superbacteria infections, and Alzheimer's disease. Its key pipeline candidate for sepsis, DD-S052P, is a novel antibiotic designed to eliminate both bacteria and their associated endotoxins to mitigate cytokine storms. For Alzheimer's disease, HLB SCIENCE is advancing DD-A279, a treatment that modulates lipopolysaccharides (LPS) and gram-negative bacteria in the central nervous system. This therapeutic effort is complemented by the development of DD-A514, a diagnostic kit for the early detection of Alzheimer's.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Dandi Bioscience Co., Ltd. It includes the meeting agenda, details on voting procedures, and financial statements (balance sheet) for the 5th fiscal year. This type of document is standard for providing shareholders with information required to vote at an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2021-03-11 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting, voting procedures, and financial statements for the purpose of informing shareholders before they cast their votes. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2021-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Dandi Bioscience Co., Ltd. It outlines the meeting date, location, agenda items (such as approval of financial statements, election of directors, and remuneration limits), and procedures for electronic voting. This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and request their participation or proxy votes.
2021-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the meeting agenda, proxy solicitation details, and financial statements for the purpose of informing shareholders before they vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2021-03-10 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) including the agenda items such as financial statement approval, director appointments, and auditor appointments. It also includes a correction notice (정정신고) regarding the auditor's status. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting details and request their participation/votes.
2021-03-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Dandi Bio. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting (AGM), including the election of directors and auditors. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the meeting and request their participation/votes. Under the provided definitions, this fits the Proxy Solicitation & Information Statement (PSI) category.
2021-03-03 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.